Nanoflex Robotics  Nanoflex 机器人

Nanoflex Robotics is a Swiss medical device company founded in 2021 as a spin-off from ETH Zurich. The company specializes in developing advanced telerobotic solutions for critical endovascular diseases, focusing on stroke and other neurovascular and cardiovascular conditions. Their mission is to make life-saving interventions accessible to all by enabling remote robotic surgery that can be deployed anywhere. The core product is the Telerobotics Intervention System (RIS), which utilizes patented magnetic navigation technology and ultra-flexible soft robotic catheters. These catheters are designed for precise movement within the vasculature and are controlled by a mobile electromagnetic system that integrates easily into standard operating rooms. The system supports remote operation, allowing physicians to perform complex procedures like mechanical thrombectomy for stroke patients from distant locations, thereby reducing treatment delays and improving patient outcomes. Nanoflex Robotics targets hospitals, physicians, and clinical partners interested in adopting innovative robotic interventions to enhance the treatment of critical endovascular diseases. Their technology aims to simplify and expedite neurovascular and cardiovascular treatments, ultimately redefining patient care and improving outcomes.

• Employees 16
• Founded 2021
• Total Funding $15186230